Gene transfer of IL-27 enhanced T cell infiltration into the tumor as well as T cell effector functions and led to a significant reduction in FoxP3+ Treg in tumors to 6.63% compared to 39.8% of FoxP3+ Tregs with control vector. This evidence concerns the gene FOXP3 and neoplasm.